Nutriband Inc. has acquired Atlanta-based 4P Therapeutics for $400,000, plus 250,000 shares of its common stock, the company announced.
4P Therapeutics is focused on drug delivery; the acquisition will allow Nutriband to buy its prescription pipeline in development. This includes products (which are in various stages of development) to treat opioid abuse/misuse, diabetes, nausea, infertility, blood pressure problems, Parkinson’s disease and pain relief, Nutriband said.
Nutriband is based in Orlando and focused on transdermal/topical technology.
